Literature DB >> 10394884

Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions.

Y Cao1, U Karsten, G Otto, P Bannasch.   

Abstract

The expression of epithelial mucins and Thomsen-Friedenreich-related antigens in preneoplastic and neoplastic hepatocellular lesions was systematically investigated using an in situ immunohistochemical staining approach. MUC1, MUC2, TF, sialosyl-TF, Tn, sialosyl-Tn, alpha2,3-linked sialic acid, and alpha2,6-linked sialic acid were examined in normal and cirrhotic human liver and in human hepatocellular carcinomas (HCCs) and cholangiocarcinomas. Normal hepatocytes and preneoplastic foci of altered hepatocytes did not express MUC1, MUC2, TF, Tn, s-Tn, or alpha2,6-linked sialic acid. In contrast, HCCs showed positive reactions for MUC1, TF, Tn, s-Tn, and alpha2,6-linked sialic acid. MUC2 was absent in normal biliary epithelial cells, but present in cholangiocarcinomas. The staining of MUC1, or s-Tn and alpha2,6-linked sialic acid in human normal liver tissues and various liver diseases did not change after specific treatments such as periodate oxidation or saponification, indicating that their expression in HCC does not result from incomplete glycosylation or low O-acetylation, respectively. MUC1, TF, Tn, s-Tn, and alpha2,6-linked sialic acid may be useful as indicators of progression of HCC in tissue sections, and perhaps also as targets for diagnostic and therapeutic approaches in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394884     DOI: 10.1007/s004280050375

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  20 in total

1.  Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.

Authors:  Wei-Ming Lin; Uwe Karsten; Steffen Goletz; Ruo-Chuan Cheng; Yi Cao
Journal:  Int J Exp Pathol       Date:  2010-11-11       Impact factor: 1.925

2.  The comparative study on ultrastructure and immunohistochemistry in AFP negative and positive hepatocellular carcinoma.

Authors:  Meirong Zheng; Youbing Ruan; Mulan Yang; Yang Guan; Zhongbi Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

3.  Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissue.

Authors:  Shi-Fang Yuan; Kai-Zong Li; Ling Wang; Ke-Feng Dou; Zhen Yan; Wei Han; Ying-Qi Zhang
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

4.  Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.

Authors:  L Tao; S Wang; L Yang; L Jiang; J Li; X Wang
Journal:  Clin Exp Immunol       Date:  2020-05-17       Impact factor: 4.330

5.  Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.

Authors:  Qian Wu; Hai-Ou Liu; Yi-Dong Liu; Wei-Si Liu; Deng Pan; Wei-Juan Zhang; Liu Yang; Qiang Fu; Jie-Jie Xu; Jian-Xin Gu
Journal:  J Biol Chem       Date:  2014-11-24       Impact factor: 5.157

6.  Glycosylations versus conformational preferences of cancer associated mucin core.

Authors:  J Schuman; D Qiu; R R Koganty; B M Longenecker; A P Campbell
Journal:  Glycoconj J       Date:  2000-12       Impact factor: 2.916

Review 7.  MUC1 in endometriosis and ovarian cancer.

Authors:  Anda M Vlad; Iulia Diaconu; Kira R Gantt
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

8.  Expression of MUC1 and CD176 (Thomsen-Friedenreich antigen) in papillary thyroid carcinomas.

Authors:  Xiang-xiang Zhan; Bing Zhao; Chang Diao; Yi Cao; Ruo-chuan Cheng
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

9.  Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.

Authors:  Giray Bozkaya; Peyda Korhan; Murat Cokaklı; Esra Erdal; Ozgül Sağol; Sedat Karademir; Christopher Korch; Neşe Atabey
Journal:  Mol Cancer       Date:  2012-09-11       Impact factor: 27.401

10.  The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma.

Authors:  Yang Ling; Jing Zhu; Lu Gao; Yongping Liu; Changtai Zhu; Rong Li; Lixin Wei; Changsong Zhang
Journal:  BMC Med Genet       Date:  2013-01-25       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.